search
Back to results

Detachable String Magnetically Controlled Capsule Endoscopy for Follow-up of Patients With Esophageal Diseases

Primary Purpose

Esophageal Diseases

Status
Recruiting
Phase
Not Applicable
Locations
China
Study Type
Interventional
Intervention
ds-MCE and EGD
Sponsored by
Changhai Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Esophageal Diseases focused on measuring esophageal diseases, capsule endoscopy

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Gender is not limited.
  2. Patients aged between 18-75 years or older.
  3. Both inpatients and outpatients.
  4. Patients with previous esophageal diseases who are scheduled to undergo EGD for follow-up.
  5. Able to provide informed consent.

Exclusion Criteria:

  1. Patients aged less than 18 years.
  2. Patients with active upper gastrointestinal bleeding.
  3. Patients who have participated in or are participating in other clinical trials within three months.
  4. Patients with cancer on active treatment with chemotherapy and/or radiation therapy.
  5. Pregnancy or suspected pregnancy.
  6. Suspected or known intestinal stenosis or other known risk factors for capsule retention.
  7. Pacemaker or other implanted electromedical devices which could interfere with magnetic resonance.
  8. Patients with dysphagia.

Sites / Locations

  • Ruijin HospitalRecruiting
  • Shanghai Changhai HospitalRecruiting
  • Shanghai General HospitalRecruiting
  • Shanghai Sixth People's HospitalRecruiting
  • Xuhui District Central HospitalRecruiting
  • Yangpu District Central HospitalRecruiting
  • Zhongshan HospitalRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

ds-MCE and EGD

Arm Description

All the enrolled participants will undergo the examination of detachable string magnetically controlled capsule endoscopy (ds-MCE) first, followed by EGD within 48 hours.

Outcomes

Primary Outcome Measures

The diagnostic accuracy of the ds-MCE in identifying esophageal diseases in comparison to standardized EGD
To assess the diagnostic accuracy of the ds-MCE as a follow-up method for patients with previous esophageal diseases, using EGD as the gold standard.

Secondary Outcome Measures

Number of quadrants visualized at Z-line by ds-MCE
To assess the visualization of Z-line. Circumferential visualization of the Z line by ds-MCE was defined by quadrants as follows: Z line not observed at all; less than 2 quadrants (< 50 %) of the Z line observed; between 2 quadrants and 3 quadrants (50 % - 75%) observed; more than 3 quadrants (> 75%) observed; and entire Z line (100 %) observed.
Scores of cleanliness of Z-line area
The effect of bubbles/saliva on the appearance of the Z line area was scored as follows: 0 = no interference by bubbles/saliva on the Z line area; 1 = minor interference of bubbles/saliva on the Z line area; 2 = major interference of bubbles/saliva on the Z line area.
Number of ds-MCE associated adverse events
To assess the safety of ds-MCE.
The patient satisfaction of the ds-MCE through questionnaires
To assess the patient satisfaction of the ds-MCE compared to standard EGD.

Full Information

First Posted
July 11, 2022
Last Updated
July 19, 2022
Sponsor
Changhai Hospital
Collaborators
Ruijin Hospital, Shanghai Zhongshan Hospital, XuHui District Central Hospital, Yangpu District Central Hospital Affiliated to Tongji University, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 6th People's Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT05469152
Brief Title
Detachable String Magnetically Controlled Capsule Endoscopy for Follow-up of Patients With Esophageal Diseases
Official Title
Accuracy of Detachable String Magnetically Controlled Capsule Endoscopy for Follow-up of Patients With Esophageal Diseases: A Multicenter Study
Study Type
Interventional

2. Study Status

Record Verification Date
July 2022
Overall Recruitment Status
Recruiting
Study Start Date
July 15, 2019 (Actual)
Primary Completion Date
September 15, 2022 (Anticipated)
Study Completion Date
September 15, 2022 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Changhai Hospital
Collaborators
Ruijin Hospital, Shanghai Zhongshan Hospital, XuHui District Central Hospital, Yangpu District Central Hospital Affiliated to Tongji University, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 6th People's Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of the study is to determine the accuracy of detachable string magnetically controlled capsule endoscopy(DS-MCE) as a follow-up method for patients with previous esophageal diseases.
Detailed Description
Esophagogastroduodenoscopy (EGD) is recognized as the gold standard for detection and follow-up of esophageal diseases,allowing for direct mucosal visualization and therapeutic intervention. EGD is however an invasive procedure and there is potential for procedure-related complications, such as perforation and bleeding.Esophageal capsule endoscopy(ECE)provides a novel noninvasive approach to visualize the esophagus.The main drawback for the use of ECE is its unreliable transit time which often renders an inadequate visualization of the esophagus.Thus investigators have developed the detachable string magnetically controlled capsule endoscopy(DS-MCE) which can control the movement of the capsule through the string. The ds-MCE system consists of two parts: the magnetically controlled capsule endoscopy (MCE) system and a transparent latex sleeve with a hollow string. The magnetically controlled capsule endoscopy (MCE) system (Ankon Technologies, Shanghai, China) detects focal lesions in the stomach with comparable accuracy with conventional EGD. One end of the hollow string is a transparent thin latex sleeve that can be wrapped on the surface of the capsule, and the other end of the string is connected to the syringe. The capsule, which is partially enclosed within the sleeve, can be actively moved in the esophagus through the control of string. In this case, investigator can examine the entire esophageal mucosa several times under real time views. The capsule then could be detached from the string system through injecting air into the hollow string with the syringe after completing the examination of esophagus. The pilot study of ds-MCE confirmed it was a feasible, safe and well-tolerated method for completely viewing esophagus and stomach, without the need for sedation. Besides, the 8-10h battery life of the ds-MCE enables complete examination of the small bowel, which provides the possibility for screening pathological changes in the entire gastrointestinal tract. This study is a prospective, multi-centered, diagnostic accuracy study. The primary outcome is the diagnostic accuracy of ds-MCE in identifying esophageal diseases. Second outcomes include the visualization and cleanliness of Z-line, safety and patient satisfaction of DS-MCE.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Esophageal Diseases
Keywords
esophageal diseases, capsule endoscopy

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
310 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
ds-MCE and EGD
Arm Type
Experimental
Arm Description
All the enrolled participants will undergo the examination of detachable string magnetically controlled capsule endoscopy (ds-MCE) first, followed by EGD within 48 hours.
Intervention Type
Diagnostic Test
Intervention Name(s)
ds-MCE and EGD
Intervention Description
Procedure of ds-MCE: The ds-MCE system mainly consists of two parts: the NaviCam magnetic capsule endoscopy guidance system and the detachable string part. The capsule, which is partially enclosed within the sleeve, can be actively moved in the esophagus through the control of string. Investigator can examine the entire esophagus several times under real time views. The capsule then could be detached from the string system through injecting air into the hollow string with the syringe after completing the examination of esophagus. Then, the examination of stomach under magnetic control and small bowel under the natural action of peristalsis follows. Procedure of EGD: The EGD will be performed using conventional upper gastrointestinal video endoscopy, according to the standard procedure at individual centers. EGD will be performed within 48 hours after ds-MCE procedure and usually during the same endoscopic session.
Primary Outcome Measure Information:
Title
The diagnostic accuracy of the ds-MCE in identifying esophageal diseases in comparison to standardized EGD
Description
To assess the diagnostic accuracy of the ds-MCE as a follow-up method for patients with previous esophageal diseases, using EGD as the gold standard.
Time Frame
2 weeks
Secondary Outcome Measure Information:
Title
Number of quadrants visualized at Z-line by ds-MCE
Description
To assess the visualization of Z-line. Circumferential visualization of the Z line by ds-MCE was defined by quadrants as follows: Z line not observed at all; less than 2 quadrants (< 50 %) of the Z line observed; between 2 quadrants and 3 quadrants (50 % - 75%) observed; more than 3 quadrants (> 75%) observed; and entire Z line (100 %) observed.
Time Frame
2 weeks
Title
Scores of cleanliness of Z-line area
Description
The effect of bubbles/saliva on the appearance of the Z line area was scored as follows: 0 = no interference by bubbles/saliva on the Z line area; 1 = minor interference of bubbles/saliva on the Z line area; 2 = major interference of bubbles/saliva on the Z line area.
Time Frame
2 weeks
Title
Number of ds-MCE associated adverse events
Description
To assess the safety of ds-MCE.
Time Frame
2 weeks
Title
The patient satisfaction of the ds-MCE through questionnaires
Description
To assess the patient satisfaction of the ds-MCE compared to standard EGD.
Time Frame
2 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Gender is not limited. Patients aged between 18-75 years or older. Both inpatients and outpatients. Patients with previous esophageal diseases who are scheduled to undergo EGD for follow-up. Able to provide informed consent. Exclusion Criteria: Patients aged less than 18 years. Patients with active upper gastrointestinal bleeding. Patients who have participated in or are participating in other clinical trials within three months. Patients with cancer on active treatment with chemotherapy and/or radiation therapy. Pregnancy or suspected pregnancy. Suspected or known intestinal stenosis or other known risk factors for capsule retention. Pacemaker or other implanted electromedical devices which could interfere with magnetic resonance. Patients with dysphagia.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Zhuan Liao
Phone
86-21-31161004
Email
liaozhuan@smmu.edu.cn
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Zhuan Liao
Organizational Affiliation
Changhai Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Ruijin Hospital
City
Shanghai
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Duowu Zou
Email
zdw_pi@163.com
Facility Name
Shanghai Changhai Hospital
City
Shanghai
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Zhuan Liao
Facility Name
Shanghai General Hospital
City
Shanghai
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Xinjian Wan
Email
slwanxj2019@163.com
Facility Name
Shanghai Sixth People's Hospital
City
Shanghai
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jinshui Zhu
Facility Name
Xuhui District Central Hospital
City
Shanghai
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Yunshi Zhong
Facility Name
Yangpu District Central Hospital
City
Shanghai
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Li Li
Email
11i10437@sina.com
Facility Name
Zhongshan Hospital
City
Shanghai
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Pinghong Zhou

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
After finishing this study, we will make the data available to other researchers: including study protocol, statistical analysis plan (SAP), informed consent form (ICF), clinical study report (CSR)
IPD Sharing Time Frame
3 years.
IPD Sharing Access Criteria
The website of the journal where the results published, and ClinicalTrials.gov web site.
Citations:
PubMed Identifier
30822803
Citation
Chen YZ, Pan J, Luo YY, Jiang X, Zou WB, Qian YY, Zhou W, Liu X, Li ZS, Liao Z. Detachable string magnetically controlled capsule endoscopy for complete viewing of the esophagus and stomach. Endoscopy. 2019 Apr;51(4):360-364. doi: 10.1055/a-0856-6845. Epub 2019 Mar 1.
Results Reference
background
PubMed Identifier
18435461
Citation
de Franchis R, Eisen GM, Laine L, Fernandez-Urien I, Herrerias JM, Brown RD, Fisher L, Vargas HE, Vargo J, Thompson J, Eliakim R. Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension. Hepatology. 2008 May;47(5):1595-603. doi: 10.1002/hep.22227.
Results Reference
background
PubMed Identifier
24429971
Citation
Chen WS, Zhu LH, Li DZ, Chen L, Wu YL, Wang W. String esophageal capsule endoscopy with real-time viewing improves visualization of the distal esophageal Z-line: a prospective, comparative study. Eur J Gastroenterol Hepatol. 2014 Mar;26(3):309-12. doi: 10.1097/MEG.0000000000000038.
Results Reference
background
PubMed Identifier
11097497
Citation
de Franchis R. Updating consensus in portal hypertension: report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol. 2000 Nov;33(5):846-52. doi: 10.1016/s0168-8278(00)80320-7. No abstract available.
Results Reference
background
PubMed Identifier
25590177
Citation
Zou WB, Hou XH, Xin L, Liu J, Bo LM, Yu GY, Liao Z, Li ZS. Magnetic-controlled capsule endoscopy vs. gastroscopy for gastric diseases: a two-center self-controlled comparative trial. Endoscopy. 2015 Jun;47(6):525-8. doi: 10.1055/s-0034-1391123. Epub 2015 Jan 15.
Results Reference
background
PubMed Identifier
27211503
Citation
Liao Z, Hou X, Lin-Hu EQ, Sheng JQ, Ge ZZ, Jiang B, Hou XH, Liu JY, Li Z, Huang QY, Zhao XJ, Li N, Gao YJ, Zhang Y, Zhou JQ, Wang XY, Liu J, Xie XP, Yang CM, Liu HL, Sun XT, Zou WB, Li ZS. Accuracy of Magnetically Controlled Capsule Endoscopy, Compared With Conventional Gastroscopy, in Detection of Gastric Diseases. Clin Gastroenterol Hepatol. 2016 Sep;14(9):1266-1273.e1. doi: 10.1016/j.cgh.2016.05.013. Epub 2016 May 20.
Results Reference
background
PubMed Identifier
19286182
Citation
Liao Z, Gao R, Xu C, Xu DF, Li ZS. Sleeve string capsule endoscopy for real-time viewing of the esophagus: a pilot study (with video). Gastrointest Endosc. 2009 Aug;70(2):201-9. doi: 10.1016/j.gie.2008.10.043. Epub 2009 Mar 14.
Results Reference
background
PubMed Identifier
25208463
Citation
Hosoe N, Naganuma M, Ogata H. Current status of capsule endoscopy through a whole digestive tract. Dig Endosc. 2015 Jan;27(2):205-15. doi: 10.1111/den.12380. Epub 2014 Oct 20.
Results Reference
background

Learn more about this trial

Detachable String Magnetically Controlled Capsule Endoscopy for Follow-up of Patients With Esophageal Diseases

We'll reach out to this number within 24 hrs